Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Alrubia

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 21, 2022
Label-Free but Still Constrained: Assessment of Global Proteomic Strategies for the Quantification of Hepatic Enzymes and TransportersJill Barber, Zubida M Al-Majdoub, Narciso Couto, et al.
Journal of Proteomics|May 10, 2022
Proteomic quantification of perturbation to pharmacokinetic target proteins in liver diseaseAreti-Maria Vasilogianni, Eman El-Khateeb, Zubida M Al-Majdoub, et al.
Molecular Omics|November 17, 2023
Complementarity of two proteomic data analysis tools in the identification of drug-metabolising enzymes and transporters in human liverAreti-Maria Vasilogianni, Sarah Alrubia, Eman El-Khateeb, et al.
Drug Design, Development and Therapy|July 7, 2025
A Randomized Controlled Pilot Study Evaluating the Safety and Efficacy of Nifuroxazide in Patients with Ulcerative ColitisHayam Ali AlRasheed, Mahmoud S Abdallah, Eman El-Khateeb, et al.
Pharmacology & Therapeutics|August 4, 2019
Quantitative mass spectrometry-based proteomics in the era of model-informed drug development: Applications in translational pharmacology and recommendations for best practiceEman El-Khateeb, Areti-Maria Vasilogianni, Sarah Alrubia, et al.
Frontiers in Pharmacology|April 28, 2023
Evaluating the safety and efficacy of the leukotriene receptor antagonist montelukast as adjuvant therapy in obese patients with type 2 diabetes mellitus: A double-blind, randomized, placebo-controlled trialEman El-Khateeb, Eman I El-Berri, Esraa M Mosalam, et al.
Analytical Biochemistry|December 5, 2024
Development and validation of a sensitive and fast bioanalytical LC-MS/MS assay for the quantitation of venetoclax and azacitidine in Rat Plasma: Application to pharmacokinetic studyManal El-Gendy, Mohamed Hefnawy, Sarah Alrubia, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 20, 2024
A guide to developing population files for physiologically-based pharmacokinetic modeling in the Simcyp SimulatorLiam Curry, Sarah Alrubia, Frederic Y Bois, et al.
Pharmacotherapy|December 2, 2025
Therapeutic Modulation of IL-6/STAT-3 and Nitric Oxide by Fenofibrate in Patients With Ulcerative Colitis: A Randomized Controlled Pilot StudyKhlood Mohammad Aldossary, Mahmoud S Abdallah, Noha Kamal, et al.
Frontiers in Medicine|February 6, 2025
Effect of a high dose atorvastatin as adjuvant therapy to mesalamine in attenuating inflammation and symptoms in patients with ulcerative colitis: a randomized controlled pilot studySumaiah J Alarfaj, Sahar M El-Haggar, Sahar K Hegazy, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 21, 2022
Label-Free but Still Constrained: Assessment of Global Proteomic Strategies for the Quantification of Hepatic Enzymes and TransportersJill Barber, Zubida M Al-Majdoub, Narciso Couto, et al.
Journal of Proteomics|May 10, 2022
Proteomic quantification of perturbation to pharmacokinetic target proteins in liver diseaseAreti-Maria Vasilogianni, Eman El-Khateeb, Zubida M Al-Majdoub, et al.
Molecular Omics|November 17, 2023
Complementarity of two proteomic data analysis tools in the identification of drug-metabolising enzymes and transporters in human liverAreti-Maria Vasilogianni, Sarah Alrubia, Eman El-Khateeb, et al.
Drug Design, Development and Therapy|July 7, 2025
A Randomized Controlled Pilot Study Evaluating the Safety and Efficacy of Nifuroxazide in Patients with Ulcerative ColitisHayam Ali AlRasheed, Mahmoud S Abdallah, Eman El-Khateeb, et al.
Pharmacology & Therapeutics|August 4, 2019
Quantitative mass spectrometry-based proteomics in the era of model-informed drug development: Applications in translational pharmacology and recommendations for best practiceEman El-Khateeb, Areti-Maria Vasilogianni, Sarah Alrubia, et al.
Frontiers in Pharmacology|April 28, 2023
Evaluating the safety and efficacy of the leukotriene receptor antagonist montelukast as adjuvant therapy in obese patients with type 2 diabetes mellitus: A double-blind, randomized, placebo-controlled trialEman El-Khateeb, Eman I El-Berri, Esraa M Mosalam, et al.
Analytical Biochemistry|December 5, 2024
Development and validation of a sensitive and fast bioanalytical LC-MS/MS assay for the quantitation of venetoclax and azacitidine in Rat Plasma: Application to pharmacokinetic studyManal El-Gendy, Mohamed Hefnawy, Sarah Alrubia, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 20, 2024
A guide to developing population files for physiologically-based pharmacokinetic modeling in the Simcyp SimulatorLiam Curry, Sarah Alrubia, Frederic Y Bois, et al.
Pharmacotherapy|December 2, 2025
Therapeutic Modulation of IL-6/STAT-3 and Nitric Oxide by Fenofibrate in Patients With Ulcerative Colitis: A Randomized Controlled Pilot StudyKhlood Mohammad Aldossary, Mahmoud S Abdallah, Noha Kamal, et al.
Frontiers in Medicine|February 6, 2025
Effect of a high dose atorvastatin as adjuvant therapy to mesalamine in attenuating inflammation and symptoms in patients with ulcerative colitis: a randomized controlled pilot studySumaiah J Alarfaj, Sahar M El-Haggar, Sahar K Hegazy, et al.
Pageof 3